BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $876,000 | -79.5% | 20,000 | -69.2% | 0.37% | -68.9% |
| Q3 2022 | $4,283,000 | -64.4% | 65,000 | -56.7% | 1.20% | -47.5% |
| Q4 2019 | $12,017,000 | -49.7% | 150,000 | -53.8% | 2.29% | -62.4% |
| Q3 2019 | $23,878,000 | -32.5% | 325,000 | -13.3% | 6.08% | -17.1% |
| Q2 2019 | $35,374,000 | +84.1% | 375,000 | +56.2% | 7.34% | +46.2% |
| Q1 2019 | $19,212,000 | +74.6% | 240,000 | +100.0% | 5.02% | +125.5% |
| Q1 2018 | $11,004,000 | -2.7% | 120,000 | -20.0% | 2.23% | -16.1% |
| Q4 2017 | $11,312,000 | +218.9% | 150,000 | +114.3% | 2.65% | +260.0% |
| Q2 2017 | $3,547,000 | -11.3% | 70,000 | -30.0% | 0.74% | -1.1% |
| Q1 2017 | $3,999,000 | – | 100,000 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |